Rapid Antigen Combo Test: COVID-19, Flu A/B, and RSV

Rapid Antigen Combo Test: COVID-19, Flu A/B, and RSV

As global healthcare systems continue to face seasonal surges of respiratory infections, timely and accurate diagnostics remain essential. BABIO, a leading Chinese manufacturer of innovative diagnostic solutions, introduces the Combo SARS-CoV-2 / Flu A and B / RSV Antigen Rapid Test Kit—a comprehensive tool designed for clinics, hospitals, and point‑of‑care settings across Europe, North America, Africa, and Southeast Asia.

This advanced kit delivers results in just 15 minutes, enabling healthcare professionals to quickly distinguish between COVID‑19, influenza A/B, and respiratory syncytial virus (RSV)—three pathogens with overlapping symptoms such as fever, cough, and sore throat. By adopting colloidal gold immunochromatography technology, the test ensures reliable sensitivity and specificity, supporting early detection and effective patient management.

Key Advantages:

• 🌍 Comprehensive Coverage: Detects SARS‑CoV‑2, Influenza A/B, and RSV in one test.

• ⚡ Rapid Results: Clear outcomes within minutes.

• 🏥 Ease of Use: No laboratory equipment required.

• 🔒 Reliable Performance: Clinically validated sensitivity and specificity.

• 📦 Convenient Packaging: Available in multiple kit sizes for diverse healthcare needs.

BABIO continues to strengthen its reputation as a trusted Chinese manufacturer of diagnostic products, supporting global efforts to combat respiratory infections.

For more details, please visit the official BABIO website: https://www.babiocorp.com

#COVID19Testing #FluSeason #RSVDetection #RapidTestKit #HealthcareInnovation #BABIO